Aberdeen Group’s Amylyx Pharmaceuticals AMLX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.73M | Sell |
738,657
-1,691,701
| -70% | -$10.8M | 0.01% | 710 |
|
|
2025
Q1 | $8.6M | Buy |
2,430,358
+707,553
| +41% | +$2.5M | 0.02% | 595 |
|
|
2024
Q4 | $6.51M | Sell |
1,722,805
-249,437
| -13% | -$943K | 0.01% | 600 |
|
|
2024
Q3 | $6.39M | Buy |
1,972,242
+1,853,995
| +1,568% | +$6.01M | 0.01% | 607 |
|
|
2024
Q2 | $225K | Hold |
118,247
| – | – | ﹤0.01% | 918 |
|
|
2024
Q1 | $336K | Sell |
118,247
-77,246
| -40% | -$219K | ﹤0.01% | 892 |
|
|
2023
Q4 | $2.88M | Buy |
+195,493
| New | +$2.88M | 0.01% | 746 |
|